Prelude Capital Management, LLC Abbott Laboratories Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $144,515 - $170,102	1,492 Added 46.93%	4,671 $472,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $172,533 - $202,408	-1,815 Reduced 36.34%	3,179 $349,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $2.07 Million - $2.4 Million	-21,381 Reduced 81.07%	4,994 $483,000
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $2.31 Million - $2.79 Million	22,648 Added 607.67%	26,375 $2.87 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $120,812 - $142,213	-1,142 Reduced 23.45%	3,727 $432,000
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $203,421 - $239,661	1,869 Added 62.3%	4,869 $584,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $315,000 - $343,260	3,000 New	3,000 $328,000
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $1.42 Million - $1.72 Million	-15,470 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $596,556 - $763,518	7,791 Added 101.46%	15,470 $1.41 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $298,709 - $436,794	-4,755 Reduced 38.24%	7,679 $606,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $824,669 - $918,049	10,504 Added 544.25%	12,434 $1.08 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $2.35 Million - $2.55 Million	-28,698 Reduced 93.7%	1,930 $161,000
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $168,862 - $196,945	-2,317 Reduced 7.03%	30,628 $2.58 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $361,759 - $437,367	5,463 Added 19.88%	32,945 $2.63 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $353,696 - $400,686	5,395 Added 24.43%	27,482 $1.99 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $160,964 - $194,183	2,647 Added 13.62%	22,087 $1.62 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $97,293 - $107,382	-1,690 Reduced 8.0%	19,440 $1.19 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $100,554 - $113,688	1,787 Added 9.24%	21,130 $1.27 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $23,619 - $25,286	440 Added 2.33%	19,343 $1.1 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $908,478 - $1.01 Million	18,903	18,903 $1.01 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.9 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.6 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.11 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.81 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.33 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account